Local research in to secondary breast cancer makes major break thorough

University of Sheffield have announced ground breaking research  into the prevention of secondary breast cancer. The research in partnership with the University of Copenhagen has found that high levels of  a particular enzyme is what leaves to secondary or metastatic breast cancer. The pioneering research, co-led by Dr Alison Gartland at the University of Sheffield’s Department of Human Metabolism, could lead to a better prognosis for cancer patients in the longer term.